recombinant human coagulation factor VIII-Fc fusion protein
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human coagulation factor VIII-Fc fusion protein, covering 2023-08-29 to 2023-08-29. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A [Phase 3]